- ¥6bn
- ¥3bn
- ¥3bn
- 52
- 31
- 31
- 29
Annual income statement for Morpho, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,073 | 1,731 | 1,997 | 2,383 | 3,301 |
| Cost of Revenue | |||||
| Gross Profit | 1,436 | 867 | 952 | 1,357 | 1,900 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,433 | 2,651 | 2,678 | 2,694 | 3,045 |
| Operating Profit | -360 | -920 | -681 | -310 | 256 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -353 | -866 | -603 | -258 | 297 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -653 | -798 | -668 | -300 | 301 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -652 | -793 | -668 | -300 | 301 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -652 | -793 | -668 | -300 | 301 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -86.2 | -139 | -118 | -50.3 | 58.7 |
| Dividends per Share |